✦ LIBER ✦

The Cost-Effectiveness of Screening for Silent Atrial Fibrillation After Ischaemic Stroke

✍ Scribed by Levin, L.Å; Husberg, M.; Rosenqvist, M.; Sobosinski-Doliwa, P.; Friberg, L.; Frykman-Kull, V.; Davidson, T.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improved screening for silent atrial fib

✍ Doliwa Sobocinski, P.; Anggardh Rooth, E.; Frykman Kull, V.; von Arbin, M.; Wall 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 142 KB

Cost-effectiveness of apixaban vs warfar

✍ Kamel, H.; Easton, J. D.; Johnston, S. C.; Kim, A. S. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 578 KB

Cost–Effectiveness of Rivaroxaban Compar

✍ Soyon Lee; Moise W. Anglade; Dan Pham; Robyn Pisacane; Jeffrey Kluger; Craig I. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 786 KB

COST-EFFECTIVENESS OF APIXABAN COMPARED

✍ Soyon Lee; Moise Anglade; Kelly Hagstrom; Joy Meng; Jeffrey Kluger; Craig Colema 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 89 KB

COST-EFFECTIVENESS OF RIVAROXABAN COMPAR

✍ Soyon Lee; Moise Anglade; Robyn Pisacane; Dan Pham; Jeffrey Kluger; Craig Colema 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Cost-effectiveness of rivaroxaban for st

✍ Morais, João; Aguiar, Carlos; McLeod, Euan; Chatzitheofilou, Ismini; Fonseca San 📂 Article 📅 2014 🏛 Elsevier ⚖ 546 KB